Understanding Evidence-Based Practice Patterns in Advanced NSCLC: An Educational/Research Initiative in Mid-Atlantic States
The goals of this initiative are to close clinical knowledge and performance gaps by providing oncology clinicians with the latest advances and emerging research in the evidence-based and personalized treatment of advanced NSCLC patients. Also, the goal is to offer expert insights, IT infrastructure and clinical workflow processes to support cancer center’s need to meet quality measures relevant to value-based care delivery to patients with advanced NSCLC. We also hope to gain insights on clinician practice patterns related to advanced NSCLC, and the correlation between advanced NSCLC patients’ reported goals of care and advanced NSCLC patients’ fit/frailty status and treatment decisions.
Achievement of National Quality Standards in Breast Cancer: A Pilot Study on the Impact of Certified Education Plus a Novel Care Planning Tool
The overall goal of this study is to evaluate the impact of the Carevive Care Planning System (CPS) technology and accredited continuing medical education on cancer center adherence to quality metrics relevant to the management of breast cancer patients (developed by ASCO and ONS). Five cancer centers will participate in the study with each site recruiting breast cancer patients. Clinicians will participate in the accredited continuing medical education and then, along with their respective patient participants, interact with the Carevive CPS™ during two visits, 6-weeks apart, with patients receiving a care plan at each visit. Provider’s patient-level adherence to 31 specific quality metrics will be evaluated by chart review at pre-test (baseline) and post-test (12 weeks), complemented by specific data extracted from the Carevive CPS platform.
Improving Clinical Trial Awareness in Non-Small Cell Lung Cancer: Pilot Testing a Novel Health Care Information Technology Platform Plus Certified Training at the Point of Care
The overall goal of the lung cancer trials study is to evaluate the impact of a novel individualized care planning/educational technology, the Carevive Care Planning System (CPS), on referral to clinical trials for recurrent or metastatic lung cancer, and patient and provider knowledge, attitudes, and beliefs about clinical trials. The study will enroll 30 patients per site over approximately six months, each of whom will participate in the CPS two-part intervention to consist of (1) clinician participation in certified training (CME) about the role of biomarkers in NSCLC treatment and new targeted and immunotherapy agents for NSCLC, and (2) use of the CPS at the point of care to identify clinical trial opportunities for patients with NSCLC interested in learning about trial participation as a treatment option, and providing personalized education to patients about trials for which they are eligible. Study outcomes will be evaluated at baseline and 6 weeks using questionnaires adapted from the literature.
Improving the Quality of Multiple Myeloma Treatment with Patient Care Plans: Pilot Testing the Impact of Certified Training and Care Planning on Symptom Management
The overall goal of the myeloma study is to evaluate the use of the Carevive Care Planning System (CPS) technology and certified training (CME) on supportive care and symptom management practices for individuals with myeloma receiving active treatment. Five cancer centers will participate in the study and will recruit 15-30 patients per site over a 6-month period. Each patient participant and his/her provider(s) will interact with the Carevive CPS during two visits, with patients receiving a personalized care plan at each visit.
Improving Surgical/Medical Oncology Collaboration for Breast Cancer Treatment Planning: Pilot Testing the Impact of Certified Training and Patient Care Planning
Neoadjuvant systemic therapy is vastly underutilized in eligible patients desiring breast conservation. Provider and institutional factors, such as provider knowledge and institutionally based care coordination networks, likely play large roles in influencing treatment patterns. In addition, patient factors such as distress and lack of information may cloud patient decision-making capabilities at this time. In this study, six cancer programs will accrue 35 newly diagnosed breast cancer patients to participate in a study over a 3-month period (n=105 breast cancer patients total). Patients will be recruited from surgical practices and will be referred to medical oncology, where they will receive a care plan that outlines initial treatment, as well as distress screening and management.